RHI
52
2
MAR
47
2
TGNA
48
5
STI
12
2
O
37
-3
MRO
50
3
PX
55
2
DOW
58
4
TEL
63
2
CL
59
-2
PSA
66
-2
TSCO
57
-3
TAP
53
2
UHS
54
-4
MUR
49
4
SYY
58
2
KHC
45
-4
INTC
41
4
THC
58
-4
KIM
51
-3
RHI
52
2
MAR
47
2
TGNA
48
5
STI
12
2
O
37
-3
MRO
50
3
PX
55
2
DOW
58
4
TEL
63
2
CL
59
-2
PSA
66
-2
TSCO
57
-3
TAP
53
2
UHS
54
-4
MUR
49
4
SYY
58
2
KHC
45
-4
INTC
41
4
THC
58
-4
KIM
51
-3
Financhill
Back

Sage Therapeutics Quote, Financials, Valuation and Earnings

Hedge fund manager warns about the market ahead

Free book prepares you for the coming uncertainty in the stock market
Sell
20

SAGE
Sage Therapeutics

Last Price:
7.61
Seasonality Move:
7.25%

7 Day Trial

ALL ACCESS PASS

$ 7

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sage Therapeutics Price Quote

$7.61
+0.09 (+1.2%)
(Updated: September 18, 2024 at 6:55 PM ET)

Sage Therapeutics Key Stats

Sell
20
Sage Therapeutics (SAGE) is a Sell
Day range:
$7.49 - $7.82
52-week range:
$7.19 - $28.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.65
P/B ratio:
0.73%
Volume:
379.6K
Avg. volume:
597K
1-year change:
-64.22%
Market cap:
$459.1M
Revenue:
$86.5M
EPS:
$-7.41

How Much Does Sage Therapeutics Make?

Is Sage Therapeutics Growing As A Company?

  • What Is Sage Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 2.5%
  • What Is Sage Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Sage Therapeutics Stock Price Performance

  • Did Sage Therapeutics Stock Go Up Last Month?
    Sage Therapeutics share price went down by -7.62% last month
  • Did SAGE's Share Price Rise Over The Last Year?
    SAGE share price fell by -64.22% over the past 1 year

What Is Sage Therapeutics 52-Week High & Low?

Sage Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sage Therapeutics?

  • How Much Debt Does Sage Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Sage Therapeutics Have?
    Cash and short term investments quarterly total is $646.8M
  • What Is Sage Therapeutics’s Book Value Per Share?
    Book value per share is 10.31

Is Sage Therapeutics Cash Flow Positive?

  • What Is SAGE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$373.7M
  • What Is Sage Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $12.1M
  • What Is Sage Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $341.5M

Sage Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    SAGE return on invested capital is -56.64%
  • What Is Sage Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -50.89%
  • What Is SAGE Return On Equity?
    ROE is a measure of profitability and is -56.64%

Sage Therapeutics Earnings Date & Stock Price

Sage Therapeutics Competitors

Sage Therapeutics Dividend Yield

Sage Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -3.43%
Revenue: 249.8% -3.87%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 17
Sell Recommendations: 0
Price Target: 14.33
Upside from Last Price: 90.6%

Major Shareholders

  • How many SAGE shares are owned by institutional investors?
    99.5M SAGE shares are owned by institutional investors
  • How many SAGE shares are owned by insiders?
    1.2M SAGE shares are owned by insiders